English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

We thank Doctor Chao et al for their advices on our recent study that whether lower-dose intravenous tissue-type plasminogen activator (tPA) for stroke is as effective and safe as the standard dose.1When we want to compare the outcomes of ≥2 treatment groups for nonrandomized study, we must adjust the difference of baseline variables. Usually, there are 2 methods for choosing baseline variables included in the multivariable model for calculating adjusted odds ratio. First, we can just choose all significant baseline variables in the univariable analysis. Second, we can choose all possible variables that may affect outcomes according to our clinical experience or the result of other studies. Which of the 2 methods is good is still a matter of debate. But the number of variables you can choose …

Response to Letter Regarding Article, “Standard-Dose Intravenous Tissue-Type Plasminogen Activator for Stroke Is Better Than Low Doses”